UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~October~~ September 314, ~~2014~~2015 (~~October~~July 36, ~~2014~~2015)

VIROPRO, INC.

(Exact Name of Registrant as Specified in Charter)

Nevada	333-06718	13-3124057
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
(State or Other Jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification No.)

2151 O'Toole Avenue, Suite 50, San Jose, CA 95131

(Address of Principal Executive Offices) (Zip Code)

650-300-5190

Registrant’s telephone number, including area code

~~794~~ (Former ~~Lexington~~Name or ~~Avenue,~~Former ~~Suite~~Address ~~3R,~~if ~~New York,~~Changed NYSince ~~10065~~ Last Report)

(Former Name or Former Address

if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events .

On ~~October~~July 36, ~~2014 the~~2015, the registrant ("Viropro") ~~sent~~commenced aan ~~letter~~action toin ~~shareholders~~the ~~discussing~~Supreme ~~its~~Court ~~revised~~of ~~strategy~~the ~~following~~State ~~Bank~~of ~~Pembangunan~~New ~~Malaysia~~York, County of New York captioned: ~~Berhad~~Viropro, ~~asserting~~Inc., ~~its~~individually ~~rights~~and ~~under~~derivatively ~~the~~on ~~terms~~behalf of aAlpha ~~loan~~Biologics ~~agreement~~Sdn itBhd ~~had~~v. ~~with~~PricewaterhouseCoopers ~~Alpha~~Advisory ~~Biologics~~Services Sdn Bhd, Index No. 652377/2015, arising out of what Viropro believes is PwCAS's willful breaches of fiduciary duty and ~~appointing~~gross negligence ain ~~Receiver~~its role as receiver and ~~Manager~~manager of Alpha. Alpha is Viropro's wholly-owned subsidiary located in Penang, Malaysia. Viropro has alleged that PwCAS has injured Viropro and Alpha due to ~~recover~~its failure to preserve and protect Alpha's property for the benefit ~~value~~of all persons interested in the estate of ~~its~~Alpha ~~loan~~as required by law and equity.

AViropro ~~copy~~also received an Order dated August 12, 2015 from Justice Bransten in the case captioned Spring Hill Bioventures SDN BHD derivatively on behalf of Viropro v. Cynthia Ekberg Tsai and Richard Serbin, Index No.654167/2013 brought in the ~~letter~~Supreme Court of the State of New York, County of New York. Justice Bransten found Cynthia Tsai guilty of spoliation and civil contempt and ordered that Viropro was entitled to an adverse inference as to fraud and breach of fiduciary duty (i.e., the ~~Viropro~~jury ~~shareholders~~will isbe ~~attached~~instructed that it should assume that the emails destroyed by Cynthia Tsai would have been adverse to ~~this~~her ~~Current~~in ~~Report~~showing oncommission ~~Form~~of ~~8-K~~fraud asand ~~Exhibit~~breach 99of fiduciary duty) and an award of Viropro's attorneys' fees and costs related to this spoliation motion.1.

Viropro issued a press release on September 11, 2015 to disclose these litigation events, a copy of which is attached to this Current Report on Form 8-K as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1 ~~Letter~~Press toRelease ~~the Viropro shareholders~~ dated ~~October~~September 311, ~~2014~~2015

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: October 3, 2014	Viropro, Inc.
Date: September 14, 2015	Viropro, Inc.
	By:	/s/ Bruce A. Cohen
		Bruce A. Cohen
		Chairman of the Board

Filing Compare · VIROPRO INC